GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers
Published inEuropean Journal of Pain, vol. 24, no. 6, p. 1094-1106
Publication date2020
Abstract
Funding
- Swiss National Science Foundation - Novel approaches to the treatment of chronic pain: translating recent discoveries in painrelated neural plasticity to clinical practice- Na+-channel modulators and subtype-selective GABAA receptor ligands
Citation (ISO format)
MATTHEY, Alain et al. GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers. In: European Journal of Pain, 2020, vol. 24, n° 6, p. 1094–1106. doi: 10.1002/ejp.1554
Main files (1)
Article (Published version)
Identifiers
- PID : unige:149695
- DOI : 10.1002/ejp.1554
- PMID : 32171038
ISSN of the journal1090-3801